DE60006054D1 - Herstellungsverfahren für Pyridinderivate - Google Patents

Herstellungsverfahren für Pyridinderivate

Info

Publication number
DE60006054D1
DE60006054D1 DE60006054T DE60006054T DE60006054D1 DE 60006054 D1 DE60006054 D1 DE 60006054D1 DE 60006054 T DE60006054 T DE 60006054T DE 60006054 T DE60006054 T DE 60006054T DE 60006054 D1 DE60006054 D1 DE 60006054D1
Authority
DE
Germany
Prior art keywords
compound
formula
chem
reacting
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006054T
Other languages
English (en)
Other versions
DE60006054T2 (de
Inventor
Hans Hilpert
Fabienne Hoffmann-Emery
Goesta Rimmler
Mark Rogers-Evans
Helmut Werner Stahr
Pius Waldmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60006054D1 publication Critical patent/DE60006054D1/de
Publication of DE60006054T2 publication Critical patent/DE60006054T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60006054T 1999-11-29 2000-11-23 Herstellungsverfahren für Pyridinderivate Expired - Lifetime DE60006054T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99123686 1999-11-29
EP99123686 1999-11-29

Publications (2)

Publication Number Publication Date
DE60006054D1 true DE60006054D1 (de) 2003-11-27
DE60006054T2 DE60006054T2 (de) 2004-07-22

Family

ID=8239482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006054T Expired - Lifetime DE60006054T2 (de) 1999-11-29 2000-11-23 Herstellungsverfahren für Pyridinderivate

Country Status (12)

Country Link
US (1) US6303790B1 (de)
EP (1) EP1103546B1 (de)
JP (1) JP3403164B2 (de)
KR (1) KR100371121B1 (de)
CN (1) CN1176908C (de)
AT (1) ATE252559T1 (de)
CA (1) CA2326815C (de)
DE (1) DE60006054T2 (de)
DK (1) DK1103546T3 (de)
ES (1) ES2208206T3 (de)
JO (1) JO2252B1 (de)
MX (1) MXPA00011670A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE1035115T5 (sv) * 1999-02-24 2015-08-04 Hoffmann La Roche 4-fenylpyridin-derivat och deras anvaendning som NK-1 receptor-antagonister
ATE253561T1 (de) * 1999-11-29 2003-11-15 Hoffmann La Roche 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-( - morpholin-4-yl-4-o-tolyl-pyridin-3-yl)- isobutyramid
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
US20030083345A1 (en) * 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
PT1474395E (pt) * 2002-02-12 2008-01-02 Smithkline Beecham Corp Derivados de nicotinamida úteis como inibidores de p38
TWI280239B (en) 2003-07-15 2007-05-01 Hoffmann La Roche Process for preparation of pyridine derivatives
JP4580426B2 (ja) 2004-07-06 2010-11-10 エフ．ホフマン−ラ ロシュ アーゲー Ｎｋ−１受容体拮抗薬の合成において中間体として使用されるカルボキサミド誘導体の製造方法
KR20070094666A (ko) 2005-02-25 2007-09-20 에프. 호프만-라 로슈 아게 약제 물질 분산성이 향상된 정제
CN103893145A (zh) * 2005-09-23 2014-07-02 弗·哈夫曼-拉罗切有限公司 新型制剂
GB0808747D0 (en) 2008-05-14 2008-06-18 Glaxo Wellcome Mfg Pte Ltd Novel compounds
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
CN105358153A (zh) 2013-07-02 2016-02-24 尤斯特拉里斯制药有限公司（以普雷舒拉纽罗作为商号） 用于预防和/或治疗ii型慢性创伤性脑病的方法
CN104003933A (zh) * 2014-05-14 2014-08-27 上海应用技术学院 一种含氟基团的3-（吡啶基-2-亚胺）丙酸乙酯类似物的制备方法
CN105061303A (zh) * 2015-08-03 2015-11-18 成都欣捷高新技术开发有限公司 一种制备奈妥吡坦关键中间体n-甲基-4-(2-甲基苯基)-6-(4-甲基-1-哌嗪基)-3-吡啶胺的新方法
CN105732488B (zh) * 2016-03-28 2018-02-16 大连理工大学 一种吡啶‑2‑甲酸脱羧合成2‑(2‑氯乙氧基)乙氧基吡啶醚化合物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745123A (en) 1986-02-18 1988-05-17 Warner-Lambert Company Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents
SE1035115T5 (sv) 1999-02-24 2015-08-04 Hoffmann La Roche 4-fenylpyridin-derivat och deras anvaendning som NK-1 receptor-antagonister

Also Published As

Publication number Publication date
JP2001151755A (ja) 2001-06-05
DE60006054T2 (de) 2004-07-22
EP1103546B1 (de) 2003-10-22
CN1176908C (zh) 2004-11-24
KR20010051922A (ko) 2001-06-25
CA2326815C (en) 2009-08-25
MXPA00011670A (es) 2002-08-20
CN1297887A (zh) 2001-06-06
CA2326815A1 (en) 2001-05-29
JO2252B1 (en) 2004-10-07
JP3403164B2 (ja) 2003-05-06
DK1103546T3 (da) 2004-02-23
ES2208206T3 (es) 2004-06-16
KR100371121B1 (ko) 2003-02-06
EP1103546A1 (de) 2001-05-30
ATE252559T1 (de) 2003-11-15
US6303790B1 (en) 2001-10-16

Similar Documents

Publication Publication Date Title
DE60006054D1 (de) Herstellungsverfahren für Pyridinderivate
BR9910326A (pt) Processo para preeparar isoxazóis, composto, processo para preparar compostos, uso de compostos, e, processo para preparar tioéteres
ATE89559T1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung.
PT787726E (pt) Novo composto, processo para a sua producao e agente tumoral
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
ATE239708T1 (de) Huperzin-derivate, ihre herstellung und ihre verwendung
DK0807630T3 (da) Heterocykliske forbindelser
ATE137220T1 (de) Benzen-, pyridin-, pyrimidinderivat
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
NO971384D0 (no) Pyrimidinylpyrazol-derivat
ATE143354T1 (de) N-alkoxymethylbenzamid-derivate und verfahren zu ihrer herstellung und ihre verwendung zur herstellung von benzamid-derivaten
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
DE69612611T2 (de) Triazin-derivate
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
ATE127449T1 (de) Anilinderivate und verfahren zu ihrer herstellung.
KR920012096A (ko) 아스타크산틴 중간체
DE59308651D1 (de) 2-perhalogenalkyl-substituierte benzimidazole, ihre herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE68913686T2 (de) Benzamidverbindungen, deren Herstellung und deren Verwendung als Pestizide.
ATE420855T1 (de) 2-substituierte vitamin-d-derivate
KR950026861A (ko) 피라졸을 함유한 프로페노익 에스테르 유도체의 제조방법
TH42384A (th) อนุพันธ์ d-โปรไลน์
KR930010000A (ko) 피리딘 유도체의 제조방법
TH11180EX (th) อนุพันธ์ต่างๆของกรดคาร์แบมิค, และการผลิตและ การ ใช้ของสารประกอบเหล่านี้
TH3536EX (th) สารประกอบชนิดใหม่ของเบนโซอิลเฟนนิลยุเรีย
TH13552EX (th) อนุพันธุ์ต่าง ๆ ของเบนโซฟิโนน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition